Spruson & Ferguson’s Post

Transform your research with our cutting-edge AI Protein Interaction Screening 🧬💻! Get reliable results in just 12 days, saving 65% in costs with no lab work required. Dive into our extensive digital libraries across diverse species 🌱🐁🦠. Learn more 👉 https://bit.ly/3yMHTry #AIScreening #BiotechInnovation

⏰Less than a week to go! Don’t forget to get your tickets, before it’s too late. Our agenda is packed with fascinating panels and talks, including: · NHS Grampian Breast Screening Programme · AI Innovations in Healthcare · Living with AI and The Data Lab Community · AI, Net Zero and Just Transition · AI Innovations in Environmental Technologies https://lnkd.in/eqVP-WWz *agenda is subject to change

After a break, we are back. Right now, the next session is on: "AI for Omics and multimodal data analytics". Tune in with Marina Chiara Garassino, partner at #I3LUNG, who talks about drug discovery through a special lecture in a virtual AI lab. #I3LUNG #lungcancer #HorizonEurope #EuropeanCommission European Commission #EUFunded #EU4Health

⚖️💬 We are excited to introduce you to the theme and members of the panel discussion held at the end of the second day of the MOSA Conference! 🗣️🤖 Five interesting people, including Dorothee Horstkötter, Stijn Denissen, Rik Wehrens, Seppe Segers, and Leonard Wee, will get together to discuss the topic “Ethical Implications of Big Data and AI in Biomedicine”. 👆🌟 Scroll through our post to get to know the members of our discussion panel. #EthicsInScience #ArtificialIntelligence #BigData #MOSAConference

𝐀𝐈 𝐀𝐂𝐓 𝐒𝐔𝐌𝐌𝐈𝐓 - 𝐏𝐚𝐧𝐞𝐥 𝐃𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧 This is the end of the AI ACT SUMMIT with the last panel discussion with Gert Bos, PhD, FRAPS from Qserve Group as a facilitator. With panelists as: 🔸Cyrille Michaud from MD101 🔸Cesare Magri from 4BetterDevices 🔸María Diez Zaera from CMG MedDev 🔸Vincent Castéras from Nexialist Thanks to all of them for the great discussions and also to all the participants. Just some KPIs. We had all along the day between 120 to 170 participants joining and leaving. With a pic of 192 participants. This is great to see all of you joining and asking all your questions. This is a reward for all the time spent on the organization. #medicaldevice #easymedicaldevice #regulatoryaffairs #aiactsummit

The TerraFlow Bio team has arrived at #CYTO2024, and we wasted no time in sampling the local cuisine! 🐟🍟 That’s not all we’re up to! Tomorrow, we’re launching terraFlow xAI, an incredible new feature of the terraFlow platform. If you're at CYTO, make sure to swing by the Innovation Showcase or visit booth #133 to learn more about how this innovative AI technology is revolutionizing flow cytometry data analysis. #cyto2024 #terraflow #ai #flowcytometry #dataanalysis

Looking forward to our “GenAI - the reality behind the hype webinar” delving into use cases and roadmap development. We had a lively discussion on GenAI at BioPharmaChem Impact with Brian Hanly and the panel - delighted to bring this discussion further. Full registration details below… #AI #GenAI #Digitalisation #lifescience

How can AI shape a brighter future for all? By tailoring drug discovery to the genetic diversity of African populations and exploring AI-driven solutions for large-scale energy storage, AI2050 Fellows Dr. Kelly Chibale and Dr. Gege Wen are working to ensure that AI benefits society by the year 2050. Learn more about how AI2050 Fellows are addressing critical challenges and pushing the boundaries of what's possible with AI: https://lnkd.in/dgkrB3DP

Excited to share our journey and exploring the fusion of AI and healthcare through our OpenHack 2024 experience : Conducted by Indian Institute of Science (IISc) Unveiling a novel perspective on using Large Language Models to address the complexities of Neurodegenerative Diseases. Our presentation at OpenHack 2024 delves into the potential of AI in transforming healthcare solutions. Ready to dive into the future of AI-driven healthcare solutions?

"Today the National Science Board (NSB) MRX gave their initial policy recommendations for merit review, and ARIS is honored to have contributed to the discussion," says Susan Renoe, ARIS executive director. MRX's six policies: 1. National Science Foundation (NSF) merit review remains the gold standard. 2. The two existing criteria meet NSF needs for merit review. 3. Strengthening broader impacts for societal benefit. 4. Strengthening intellectual merit to promote the progress of science. 5. Portfolio monitoring to make sure it is achieving NSF’s goals and mission. 6. Strengthening broadening participation across merit review. Send feedback to meritreviewcommission@nsf.gov. The MRX is collecting feedback through its preliminary report in July and final report in December 2024. #BroaderImpacts